Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manja Meggendorfer

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
International Journal of Hematology|September 4, 2025
Sequential occurrence of BCR::ABL1-negative MPN and CML and vice versa: results from a real world cohortKatrin Schweneker, Miriam Lenk, Wolfgang Kern, et al.
Cancer Genetics|November 8, 2019
Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemiaCalogero Vetro, Torsten Haferlach, Manja Meggendorfer, et al.
British Journal of Haematology|July 23, 2016
Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia veraSabit Delic, Dominic Rose, Wolfgang Kern, et al.
Cancer Genetics|May 20, 2025
Potential factors underlying the progression of RUNX1-mutated MDS to AMLAnna Stengel, Katharina Hörst, Constanze Kühn, et al.
BMC Cancer|August 3, 2021
Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemiaWencke Walter, Rabia Shahswar, Anna Stengel, et al.
Blood Reviews|October 14, 2022
Artificial intelligence in hematological diagnostics: Game changer or gadget?Wencke Walter, Christian Pohlkamp, Manja Meggendorfer, et al.
Haematologica|April 10, 2025
Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case reportJana Wobst, Marietta Truger, Constance Baer, et al.
Hemasphere|November 15, 2019
Molecular characterization of AML with <i>RUNX1-RUNX1T1</i> at diagnosis and relapse reveals net loss of co-mutationsAlexander Höllein, Niroshan Nadarajah, Manja Meggendorfer, et al.
Blood Advances|September 27, 2021
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignanciesAnna Stengel, Constance Baer, Wencke Walter, et al.
Cytometry. Part B, Clinical Cytometry|January 28, 2022
Identification of a specific immunophenotype associated with a consistent pattern of genetic mutations including SRFS2 and gene expression profile in MDSElisabeth Weiß, Wencke Walter, Manja Meggendorfer, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
International Journal of Hematology|September 4, 2025
Sequential occurrence of BCR::ABL1-negative MPN and CML and vice versa: results from a real world cohortKatrin Schweneker, Miriam Lenk, Wolfgang Kern, et al.
Cancer Genetics|November 8, 2019
Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemiaCalogero Vetro, Torsten Haferlach, Manja Meggendorfer, et al.
British Journal of Haematology|July 23, 2016
Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia veraSabit Delic, Dominic Rose, Wolfgang Kern, et al.
Cancer Genetics|May 20, 2025
Potential factors underlying the progression of RUNX1-mutated MDS to AMLAnna Stengel, Katharina Hörst, Constanze Kühn, et al.
BMC Cancer|August 3, 2021
Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemiaWencke Walter, Rabia Shahswar, Anna Stengel, et al.
Blood Reviews|October 14, 2022
Artificial intelligence in hematological diagnostics: Game changer or gadget?Wencke Walter, Christian Pohlkamp, Manja Meggendorfer, et al.
Haematologica|April 10, 2025
Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case reportJana Wobst, Marietta Truger, Constance Baer, et al.
Hemasphere|November 15, 2019
Molecular characterization of AML with <i>RUNX1-RUNX1T1</i> at diagnosis and relapse reveals net loss of co-mutationsAlexander Höllein, Niroshan Nadarajah, Manja Meggendorfer, et al.
Blood Advances|September 27, 2021
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignanciesAnna Stengel, Constance Baer, Wencke Walter, et al.
Cytometry. Part B, Clinical Cytometry|January 28, 2022
Identification of a specific immunophenotype associated with a consistent pattern of genetic mutations including SRFS2 and gene expression profile in MDSElisabeth Weiß, Wencke Walter, Manja Meggendorfer, et al.
Pageof 13